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Abstract 
Composite biomaterials based on proteins and inorganic fillers are highly attractive for wound 
dressing applications due to their highly absorbent properties towards blood and exudate 
provided by the inorganic fillers. Moreover, such composites offer a desirable environment 
for cells due to the combination of organic and inorganic characteristics. This study highlights 
the fabrication of soy protein isolate/nanoscale bioactive glass composite films by solvent 
casting method as a matrix for wound-dressing applications. The effect of the addition of 
bioactive glass nano particles on blood clotting was assessed. Cytotoxicity and in vitro 
cytocompatibility of the ﬁlms were also tested. The results showed that the composite films 
could meet the essential requirements for an appropriate wound dressing with additional 
favorable properties such as hemostatic capability and mechanical properties as well as 
significant cell cytocompatibility. 
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1. Introduction 
Naturally derived materials like proteins are widely investigated in biomedical applications. 
In this regard, soy protein is considered to exhibit beneficial properties over other proteins 
such as high storage capability, being of non-animal origin and inexpensive [1]. Many reports 
have been published about biomedical applications of pure soy protein or blending with other 
polymers or macromolecules [2–9]. For instance, it was found that soy protein granules could 
be used as inexpensive bone fillers due to their mechanical stability, anti-inflammatory 
capability and ability to induce osteoblast differentiation by the action of intrinsic isoflavones 
in vitro [4,5] and in vivo [6]. Other studies have shown that soy protein films were nontoxic 
and promoted cell proliferation [7] while soy membranes with controlled antibacterial release 
could be an option for wound dressing applications [8]. Moreover, soy protein/alginate 
hydrogel films were shown to support the attachment, spreading, and proliferation of mouse 
fibroblast cells for soft tissue engineering applications [9]. 
Bioactive glasses (BGs) such as other inorganic materials are attractive materials for hard 
tissue engineering, like in bone and dental regeneration. Recently, BGs have started to be 
considered for soft tissue regeneration and wound healing applications [10]. For instance, 
Ostomel et al. [11] used silicate glasses as hemostasis inducing materials for blood clot 
formation, highlighting that bioactive glasses can release Ca+2 ions to support the coagulation 
cascade [11]. In another study [12], 1% silver doped mesoporous bioactive glass showed no 
toxicity against fibroblasts in addition to inducing an antibacterial effect. Bioactive glass 
containing biopolymers are therefore an alternative option for treating burn wounds [12]. 
Moreover, bioactive glasses exhibit angiogenic capacity due to the effect of ionic dissolution 
products [13] release and can therefore be used as wound healing materials. However, due to 
the brittleness and sharp morphology of bioactive glass particles, which can create 
inflammatory response or cell damage, BG particles are usually combined with biopolymers 
forming composite materials for wound healing applications [14]. BG particles alone do not 
have appropriate mechanical stability for wound treatment and due to their sharp morphology 
they can induce inflammatory reactions [14]. Therefore, the development of new organic-
inorganic composite biomaterials which have proper mechanical properties and degradability 
while maintaining other bioactive attributes of inorganic components is inevitable for soft 
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tissue engineering and wound healing applications. In this context, the combination of BGs 
and biodegradable polymers to attain flexible composites for soft tissue engineering and 
wound healing is gaining increasing interest [14–17]. For example, Moura et al. [17] 
fabricated composite electrospun fibrous membranes containing polycaprolactone 
incorporating silver-cobalt doped bioactive glass nanoparticles for wound healing 
applications. Ma et al. [18] fabricated composite BG-gelatin/chitosan nanofibrous membranes 
by electrospinning to develop biomaterials for repairing chronic and non-healing wounds. 
Zeng et al. [19] illustrated that composite BG-alginate/agarose hydrogels promoted cell 
migration and angiogenesis both in vitro and in vivo by providing a suitable moist 
environment and releasing bioactive ions for chronic wound healing.  
The main goal of this investigation was the fabrication of soy protein isolate membranes with 
and without addition of bioactive glass nanoparticles intended for applications as wound 
dressing materials exploiting the complementary properties of both biomaterials. In this study 
the complete characterization of the membranes is presented, such as mechanical properties, 
clotting capability, degradation behavior and in vitro cytocompatibility. 
 
2. Materials and methods 
2.1 Materials  
Two different kinds of soy protein isolate (SPI) containing minimum 90 wt.% protein were 
acquired from NowSports (England) and MP Biomedicals (USA). Some of the 
characterization experiments were done only on films produced by soy protein isolate  from 
NowSports. This is a human dietary product containing also some minerals and additives, 
such as iron and sugar, therefore, the SPI from MP Biomedicals was chosen for further 
investigations. Glycerol was purchased from VWR International (Belgium). Three different 
kinds of nanosized bioactive glass (nBG) particles were considered (mean particle size 20-80 
nm). The compositions of the nBG were very close to i) 45S5 composition (47.8 wt% SiO2, 
25.1 wt% CaO, 22.6 wt% Na2O, 4.6 wt% P2O5) [20], ii) 13-93 BG (53 wt.% SiO2, 20 wt.% 
CaO, 6 wt.% Na2O, 4 wt.% P2O5, 12 wt.% K2O, 5 wt.% MgO ) and iii) 13-93-5Sr (mean 
particle size 30-35 nm)  composition (53 wt.% SiO2, 15 wt.% CaO, 6 wt.% Na2O, 4 wt.% 
P2O5, 12 wt.% K2O, 5 wt.% MgO, 5 wt.% SrO). These glass nano powders were fabricated by 
the flame spray method [20,21]. 
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2.2 Preparation and characterization of soy protein films 
SPI films were prepared by the solvent-casting method. SPI solutions were prepared by 
dissolving 2% w/v SPI with constant stirring in ultra-pure water. It should be also mentioned 
that 2 %( w/v) SPI in water at pH around 7 was almost the maximum concentration of SPI 
which can be significantly dissolved in water and for higher concentration of SPI increase of 
the solution pH is inevitable [8,22]. Then the plasticizer (2% w/v glycerol, w/w% relative to 
SPI) was added to the solution under constant stirring. While being stirred, the solution was 
heated at a constant temperature of 60˚C for 45 min and then 0.5 % w/v nBG was added. The 
blend solution was further subjected to an ultrasound treatment. The sonication treatment of 
the blend solution was carried out for 3 min. A pulsed duty cycle of ‘‘8 s on, 2 s off’’ was 
used. The parameters for ultra-sonication were optimized according to a previous 
investigation [23]. The ultrasonic treatment was applied with the probe type ultrasound source 
“20kHz Vibracell CV33” (Sonics & Materials, USA). Finally, 25 ml of the solution was cast 
into Teflon molds and dried at ambient temperature for 2-3 days. Subsequently, a thermal 
treatment at 80°C for 24 h was carried out in an oven. Dried films were then cut by punching 
in order to obtain pieces of circular shape (diameter 13.5 mm). The nominal thickness of the 
dried films was 0.15-0.22 mm. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) was carried out for 
MP Biomedicals SPI solution by using the OmniPAGE TETRAD Package from Cleaver 
Scientific Ltd. The resolving gels (10% acrylamide of about 1.5 mm thickness) were run at a 
constant voltage (120 V) and prepared according to the method described by Laemmli [24]. 
Proteins were visualized by Coomassie Brilliant blue G 250 staining using the Prestained 
Page Ruler marker (Thermo Scientific) for calibration. 
 
2.2.1 Physico-chemical properties of the films 
i.Swelling and degradation behavior 
For swelling and degradation measurements the films were previously sterilized by UV light 
(power (15 W)) for an hour. The dried SPI films (Wd) with and without bioactive glass 
additions were incubated in Hanks' balanced salt solution (HBSS, Sigma-Aldrich, Germany) 
with 1% (v/v) antibiotic-antimycotic for up to 28 days at 37 ˚C. After specific time intervals, 
films were taken from the medium and then the remaining liquid adhered to the surfaces was 
removed from the samples, which were weighed (Wt) with an analytical balance (Scaltec, 
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Germany). The swelling and degradation of the films were calculated according to the 
following equation: 
Swelling and degradation (%) = (Wt -Wd) / Wd ×100           (1) 
where positive values are considered as swelling (w %) and negative values are considered as 
degradation (w %). Every experiment was repeated 5 times (n=5) and after calculating the 
swelling and degradation for each sample, the average values were determined. 
 
ii.Weight Loss 
The degradation of the films after 28 days of incubation in HBSS was investigated. The last 
time point was chosen at 28 days, according to the study reported by Peles et al. [8] which 
was considered a suitable time for studying weight loss of wound dressing biomaterials. The 
weight of the dried samples was measured before and after incubation. The percentage of 
weight loss was calculated using eqn. (2), where Wi and Wf correspond to the initial and final 
dried sample weights, respectively: 
Weight loss (%) = ((Wi-Wf))/Wi ×100                 (2)     
Every experiment was repeated 5 times.      
 
iii.Fourier transform infrared spectroscopy (FTIR)  
The chemical structure of the samples was assessed by FTIR (IRAffinity-1S, Shimadzu, 
Japan). The analysis was performed under the following conditions: spectral range between 
4000 and 400 cm-1, 32 scans at a resolution of 4 cm-1 were recorded. SPI films with and 
without bioactive glasses of both soy protein films were used to record attenuated total 
reflectance Fourier transform infrared (ATR FTIR) spectra. 
 
iv.Scanning electron microscopy (SEM) 
 The morphological analysis of the films was performed using scanning electron microscopy 
(SEM) (Auriga CrossBeam, Carl Zeiss Microscopy GmbH, Germany). The samples for SEM 
were sputter coated with gold (Sputter Q150T, Quorum Technologies, Darmstadt, Germany) 
before SEM examination. 
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For SEM images of cells adherent on the 13-93 BG films after 5 days of cultivation, , films 
were first washed with HBSS and fixation was conducted by using glutaraldehyde and 
paraformaldehyde composing fixation buffer. Then films were dehydrated in a graded ethanol 
series (30, 50, 70, 80, 90, 95, and 99.8 v %). At the end the films were critical-point dried 
(Leica EM CPD300, Germany) and sputter-coated with gold prior to SEM examination. 
v.Clotting assay 
Blood clotting experiments were performed to analyze the hemostatic properties of films with 
different bioactive glasses. The clotting assay was conducted according to the following 
protocol [25]. First, membranes were pre-warmed in a 37°C incubator in polypropylene tubes. 
Then, 200µl citrate whole blood was added to all membranes. Also 20µl 0.2M CaCl2 (starting 
coagulation) was added. Afterwards, all tubes were incubated at 37°C and 30 rpm (orbital 
shaker) for 10 min. Then the membranes and clots were removed and non-clotted blood was 
added into 25 ml distilled water (by putting the open 1.5 ml tubes into a 50 ml falcon tube 
with 25 ml distilled water) and it was shaken gently for 1 min. Thereby, non-clotted blood 
was hemolyzed. Remaining fragments of the clot were pelleted by centrifugation at 200 g for 
5 min. Finally, the absorption of hemolyzed blood was measured at 540 nm. The control was 
performed also in polypropylene tubes without the membrane. 
vi.Tensile mechanical properties 
Standard tensile strength testing was performed on SPI films (made from NowSports soy 
protein isolate) with and without three different kinds of nBGs with dimensions of 40mm x 
5mm using a Z050 machine (Zwick Roell, Germany). The films were held tightly between 
two metal restraints with a gauge length of 20mm and in order to avoid damage while 
inserting the samples, the ends were covered with tissue paper. After an initial load of 0.1N 
the measurements were carried out using a loading speed of 1mm/min. Subsequently, a load 
of 50N at a speed of 10mm/min was applied until failure occurred. The Young’s modulus was 
estimated from the slope of the stress versus strain curves. Every experiment was repeated 4 
times (n=4). 
 
vii.Thermogravimetric analysis 
Thermogravimetric analysis was carried out with a SETARAM SETSYS TG-DTA 16/18 
instrument. Samples were placed in alumina crucibles. An empty alumina crucible was used 
as reference. SPI films made from NowSports (with and without nBGs) were heated from 
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ambient temperature to 700 °C in a 50 ml/min flow of N2 at a heating rate of 10 °C/min. 
Continuous recordings of sample temperature, sample weight and heat flow were taken.  
2.2.2 In vitro cell study 
The prepared circular films of SPI (MP Biomedicals) with and without nBGs were placed in 
24-well plates. For sterilization, films were exposed to UV irradiation for an hour. All films 
were then pre incubated in Dulbecco's Modified Eagle Medium (DMEM), 10% Fetal Calf 
serum (FCS) and 1% antibiotic (penicillin and streptomycin) during night.   
Mouse embryonic fibroblast cells (MEF cells) were grown in cell culture flask containing 
DMEM, 10% FCS, 1% non-essential amino acids and 1% antibiotic (penicillin and 
streptomycin) for 48 hours. Afterwards the cells were harvested by trypsin and 50,000 cells 
were seeded per each sample and incubated in a humidified atmosphere of 95% relative 
humidity and 7.5% CO2, at 37 ˚C for 2 and 5 days. To evaluate the growth and morphology of 
the selected cell density, MEF cells grown on standard cell culture plastic were used as a 
reference.  The culture medium was changed after two days. To investigate the metabolism of 
the MEF cells on the films after 2 and 5 days of incubation, the viability of cells was 
evaluated by the WST-8 assay. To assess the viability of cells, live staining was performed 
with Vybrant® (DiI) (Thermo Fisher ScientificTM, USA) and nuclei staining was done by blue 
nucleic acid stain, DAPI (InvitrogenTM, USA). For higher clarity of images and better 
recognition, the blue nucleic acid stain was changed to green color. The images of Vybrant-
DAPI stained cells were taken by fluorescence microscopy (Axio Scope A.1, Carl Zeiss 
Microimaging GmbH, Germany). 
3. Results and discussion 
3.1 SDS–PAGE 
The SPI solution was characterized by SDS–PAGE electrophoresis in order to analyze its 
molecular weight (kDa). Results are shown in Fig. 1a, 1b. As it is observed in Figure 1b and 
according to Silva et al. [26], both SPI solutions illustrate the main band for glycinin 
polypeptides and subunits of β-conglycinin. β-conglycinin with trimeric structure is composed 
of three major subunits, namely α, α׳ and β, with masses of about 70 (α and α׳ subunits) and 
48 kDa (β), respectively [27,28]. In addition, soy glycinin with a molecular mass of 
approximately 350 kDa consists of 6 A–B subunits composed of an acidic polypeptide (A) 
and a basic polypeptide (B) linked by a disulphide bridge. The mass of the acidic polypeptide 
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is about 38 kDa and the basic polypeptide mass is about 20 kDa, which can be seen in Figure 
1 as well [26,29].  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
3.2 Physico-chemical properties of the films 
i. Swelling and degradation behavior 
In vitro swelling and degradation of the SPI (MP Biomedicals) films were investigated by 
measuring the weight gain and weight loss of the films during different incubation times in 
HBSS, at 37 °C, in a controlled atmosphere of 5% CO2 and 95% relative humidity. As shown 
in Figure 2, at the beginning of incubation, swelling of all films was observed, which was 
slightly higher for the films containing bioactive glasses. Then, a decreasing trend was 
observed, however this trend was not significant until 28 days of incubation. Removing the 
excess HBSS from the small SPI membranes before weighting was difficult. In that case, until 
28 days of incubation, degradation is not detected, perhaps due to incomplete removal of the 
liquid from the samples.  
a) b) 
 
 
glycinin polypeptides 
β-conglycinin subunits 
Figure 1: SDS–PAGE of both soy protein solutions, a) NowSports (Reproduced with permission 
from [26], Copyright 2018, Elsevier.) and b) MP biomedicals. Subunits of b-conglycinin and 
glycinin polypeptides are seen in the gels. 
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ii. Weight loss 
The weight of dried films after 28 days of incubation was measured and the results (Figure 3) 
depict degradation of up to 55% weight loss for all SPI films. However, this result showed no 
difference in the degradation rate regarding the addition of nBGs, which indicates that 
degradation is likely due to the release of SPI and not due to interaction of the HBSS with 
bioactive glass. Silva et al. [26] have reported similar results for SPI-alginate hydrogel films 
immersed in simulated body fluid (SBF).     
 
 
 
 
 
 
 
  
Figure 2: Swelling of SPI and SPI composite films during 28 days of incubation in HBSS, 
indicating no degradation of the samples. 
Figure 3: Weight loss of SPI and SPI composite films after 28 days of incubation in HBSS 
(n=5). No significant difference was observed between all different types of films. 
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iii. FTIR study 
Figure 4 shows FTIR spectra of SPI films with and without BGs. The peaks of amides I, II, III 
and A are typical for proteins and they are all found in the FTIR spectrum of both SPI films 
(NowSports and MP Biomedicals). Amide I at 1645cm-1 is typical for the C=O stretching 
vibration [30,31]. Amide II at 1550 cm-1 belongs to the N-H bending vibration and C-N 
stretching vibration. The small peak for Amide III at about 1300 cm-1 relates to N-H bending 
vibration and C-N stretching vibration like Amid II [30,31]. The wide range from 3200 cm-1 
to 3600 cm-1 belongs to the Amide A structure indicating the N-H stretching vibration 
[31,32]. Addition of nBG is not detected in the FTIR spectrum due to the covering with 
polymeric components of the films. This result is in agreement with the surface morphology 
of the films observed in SEM images (Figure 5) that show no nBG particle exposed on the 
surface. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: FTIR spectrum of both SPI films with and without nBG, relevant peaks are discussed 
in the text.  
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iv. SEM analysis 
The surface topography of SPI films (MP Biomedicals) was investigated by SEM (Figure 5). 
SPI films exhibited a smooth surface, while the addition of nBG led to a rough surface owing 
to the interaction between BG and protein. However, this interaction was stronger for 45S5 
and 13-93-5Sr nBGs in comparison to the 13-93 nBG. Tian et al. [33] have reported that silica 
nano particles changed the surface morphology of soy protein films to a rough surface. 
Moreover, silica exhibited uniform distribution in the protein matrix specially for contents 
below 15 wt% [33], which is observed in this study for the films with nBG.  
 
 
 
 
 
 
 
 
 
 
 
 
 
v. Clotting assay 
The first stage of wound healing is hemostasis which starts by aggregation of platelets and 
clot formation to control bleeding [2]. A clotting assay was performed in order to understand 
the effect of nBG on the clotting ability of SPI-based films. Figure 6 shows the absorbance of 
non-clotted hemolyzed blood in water. Higher absorbance value indicates a slower clotting 
rate. As it can be seen in Figure 6 both SPI films without nBG and the control show similar 
SPI SPI+ 45S5 
SPI+13-93-5Sr SPI+13-93 
a b 
c d 
Figure 5: SEM images of SPI films (MP Biomedicals) with and without nBG, a) SPI, b) SPI/45S5, c) 
SPI/13-93, d) SPI/13-93-5Sr. 
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results and they are not significantly different from each other, however, for the films with 
nBG, a better coagulation effect is observed in comparison to the control, especially for 13-93 
and 13-93-5Sr nBGs. Statistical analyses were accomplished by one-way analysis of variance 
(ANOVA) on all samples. The pairwise comparison of the means was performed with the 
Bonferroni’s test (post hoc comparison). Both Ca+2 and Mg+2 ions play a critical role in 
stabilizing the conformation of coagulation factor IX in the blood-clotting cascade [34]. 
Moreover, Ostomel et al. [11] demonstrated that the fastest hemostatic response belongs to 
BG compositions with a high Si/Ca ratio. In this case, SPI films with 13-93 and 13-93-5Sr 
nBGs show better clotting profile in comparison to SPI films with 45S5 nBG especially for 
the MP Biomedicals SPI films, a result which might be due to the higher Si/Ca ratio in both 
13-93 and 13-93-5Sr nBGs in comparison to 45S5 nBG. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Clotting assay of both types of SPI films with and without nBGs. Significant differences 
are indicated in comparison to control: *p < 0.05, **p < 0.01 and ***p < 0.001 (Bonferroni's 
posthoc test) (n=3). 
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vi. Mechanical properties 
The mechanical behavior of the SPI (NowSports) films with and without nBG was analyzed 
at room temperature. Table 1 shows the Young’s modulus and ultimate tensile strength (UTS) 
values for different films. Typical curves are plotted in Figure 7. Normally the addition of 
inorganic filler should increase the stiffness and Young’s modulus of polymeric films [35]. 
However, an increase of Young’s modulus was not obtained in the present 45S5 and 13-93-
5Sr films (Figure 8). The reason might be the poor interaction of these two nBGs with SPI 
leading to defects in the microstructure (e.g. internal cracks due to the lack of cohesion at the 
BG/SPI interfaces). Also SEM images confirmed that SPI+13-93 films had homogenous and 
smooth surfaces in comparison to the other films which could lead to higher Young’s 
modulus.   
 
Table 1: Mechanical characteristics of different SPI (NowSports) films with and without nBG. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Films SPI SPI+45S5 SPI+13-93  SPI+13-93-5Sr 
Young’s modulus [MPa] 23.0±0.7   10±1     29±2         20±4 
UTS [MPa] 3.70±0.09 1.7±0.2 4.7±0.4 3.7±0.7 
Figure 7: Typical stress vs strain curves of SPI (NowSports) composite 
films. 
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vii. Thermogravimetric analysis (TGA) 
TGA was performed to analyze the thermal stability of the composite films (NowSports). As 
expected, the results (Figure 9) show that BG is thermally stable in the temperature range 
between room temperature and 750 ˚C. The evaporation of water in the temperature range 
between room temperature and 120 ˚C, the evaporation of glycerol in the range between 120 
˚C and 280 ˚C and the SPI degradation above 280 ˚C were detected by TGA [33]. The total 
residual mass of approximately 10 wt. % at the end of the experiment belongs to the BG 
component considering the elimination of the organic phases of the sample. 
 
 
 
 
Figure 8: Young’s modulus of SPI films (NowSports) with and without bioactive glass filler. 
Significant differences are indicated in comparison to control: *p < 0.05, **p < 0.01 and 
***p < 0.001 (Bonferroni's posthoc test). 
SPI SPI+45S5 SPI+13-93 SPI+13-93-5Sr 
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3.3 Cell culture study 
To investigate the metabolic activity of MEF cells on top of SPI films, the WST-8 test was 
performed. As shown in Figure 10, although the overall metabolic activity remained lower on 
SPI-based films than on standard cell culture plastic (for values on plastic, see Table 2), the 
presence of nBG in the films improved the mitochondrial activity of MEF cells after 2 days of 
cultivation. During the incubation time, the measured metabolic activity of MEF cells on all 
SPI films increased, owing to the proliferation of cells. Interestingly, the metabolic activity 
was significantly higher in cells grown on SPI-13-93 nBG composite films compared to the 
other types of films after 5 days of cultivation, possibly due to the better interaction of BG 
nanoparticles with SPI. SPI-13-93-5Sr nBG films showed also higher cell vitality after 2 days 
of incubation compared  to pure SPI films, however, after 5 days incubation, a similar result 
10% 
Figure 9: TGA of SPI (NowSports) composite films with and without BG. 
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for both SPI and SPI-13-93-5Sr nBG films was obtained. SPI+45S5 nBG films showed 
similar results to pure SPI films and the reason could have been the faster degradation of 45S5 
nBG compared to BGs of the 13-93 composition family [36]. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Mitochondrial activity of MEF cells grown on standard cell culture plastic. Absorbance at 
450 nm, reflecting enzymatic conversion of tetrazolium salt (WST-assay), was measured on day 2, day 
4 and day 7. Fold change relative of pure SPI values is shown ± SD of hexaplicate samples. 
 
   
 
Seeding density Day 2 Day 4 Day 7 
30,000 cells/well 8±0.5 12±0.9 11±0.3 
50,000 cells/well 10.7±0.5 14±0.6 11±0.2 
100,000 cells/well 10.2±0.8 13.2±0.7 11.4±0.4 
Figure 10: Metabolic activity of MEF cells on SPI films (MP Biomedicals) with and without BG 
fillers after 2 and 5 days of cultivation. Metabolic activity of MEF cells grown on pure SPI for 2 
days was set to 1. Significant differences are indicated in comparison to control: *p < 0.05, **p < 
0.01 and ***p < 0.001 (Bonferroni's posthoc test). 
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The metabolic activity and morphology of living cells were in parallel evaluated by using 
Vybrant® (DiI), the lipophilic membrane dye which can easily stain the outer membrane of 
living cells [37]. In order to assess the integrity of the nucleus, a nucleic acid staining was 
performed using DAPI [38]. To obtain a better contrast, the blue color of the nucleus was 
digitally changed to green. Figure 11 shows a rapid growth of MEF cells and good surface 
coverage on the pure SPI (Fig. 11a, b) and on composite films containing nBG of 13-93 
based-composition. The number of cells on top of the 13-93 group films was markedly higher 
compared to those on SPI-45S5 films after 2 days. Moreover, the results after 5 days of 
incubation (Figure 12) showed higher number of cells growing on pure SPI, SPI-13-93 nBG 
and SPI 13-93-5 Sr nBG films as compared to SPI-45S5 films. Notably, the fluorescent 
imaging of cells colonizing the surface of the 45S5 nBG-containing films after 2 days of 
incubation indicated a lower number of cells in comparison to the other types of films, which 
disagreed with the results of WST-8 assay. According to the metabolic activity assay, the 
fluorescent imaging results of pure SPI films should be comparable to those of 45S5-
containing films. However, a lower number of cells was detected on the surfaces of SPI-45S5 
BG films compared to pure SPI films, both after 2 and 5 days of incubation. Therefore, the 
surfaces of the well plates containing SPI-45S5 films were examined by fluorescent 
microscopy.  As shown in the insert of Fig. 11, the presence of cell clusters on the bottom of 
the wells, under the 45S5 BG-containing films, was observed. This indicates that the rapid 
cell attachment to the SPI-45S5 nBG films surface was prevented, resulting in MEF cell 
growth below these films on the well plates. Such effect could be explained by different 
characteristics of these films, which did not closely stick to the bottom of the wells and were 
prone to bending after cell seeding, or due to an insufficient biocompatibility of the surface. 
The WST-8 results for this type of sample must therefore be treated with caution, and ideally, 
for the purpose of future investigations, the films should be transferred to a separate well plate 
before the metabolic activity measurements, to avoid interference from cells colonizing the 
bottom of the wells. It is important to note that this effect was not observed in any of the other 
films. 
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Previous studies have indicated that the stiffness of the substrate could have an effect on the 
adhesion properties of fibroblasts [39,40]. More recently, a study on human fibroblasts 
showed a clear dependence of fibroblast adhesion and proliferation on the substrate elastic 
modulus [41]. The number of adherent cells after 24 h and 6 days post-seeding gradually 
increased with growing stiffness of the substrate surface, within the range of 0.5 MPa and 120 
MPa. In our study, the observed density of MEF cells grown on different substrates 
On the well plate 
Figure 11: Fluorescent staining with Vybrant-Dapi of MEF cells on the SPI (MP Biomedicals) composites 
films after 2 days. 
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corresponds to the data in Figure 8, showing the Young’s modulus of SPI composite films, 
which indicates a correlation between cell proliferation and mechanical properties of the 
films. The higher Young’s modulus of pure SPI, SPI-13-93 nBG and SPI 13-93-5 Sr nBG 
films could therefore positively affect the cell viability compared to SPI-45S5 films, with 
Young’s modulus of about 1 MPa. This might also be the reason explaining why films 
containing 13-93 nBG, due to their highest value of the elastic modulus, showed better cell 
attachment and proliferation compared to other films. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Fluorescent staining with Vybrant-Dapi of MEF cells on SPI (MP 
Biomedicals) films with nBG fillers after 5 days. 
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The cytocompatibility of the 13-93 nBG films was also confirmed by SEM images (Figure 
13). In Figure 13, multiple layers of MEF cells, which were anchored on the surface of 13-93 
nBG films with their growing filopodia, are shown. These results seem to correlate with SEM 
images of the surface of the films (Fig. 5) showing the smoothest surface for SPI-13-93 nBG 
in comparison to the other composite films. Previous reports have shown that, whereas 
fibroblast attachment and proliferation are positively influenced on flat polystyrene cell 
culture dishes with increasing nanoscale roughness (ranging between 1-6 nm) [42], cell 
attachment and growth are progressively inhibited on substrates with surface nanoroughness 
of 30 nm and higher [43]. The relative smoothness of the SPI-13-93 nBG films could 
therefore be another reason for better cell attachment and proliferation on these samples. 
 
 
a 
 
 
 
 
 
 
 
4. Conclusions  
In this study, the development and characterization of novel biodegradable materials based on 
soy protein isolate composite ﬁlms containing BG nanoparticles were presented. Degradation 
studies demonstrated up to 55% weight loss during 28 days of incubation for all types of 
films. Being proposed for hemostatic wound dressing, a coagulation assay was performed on 
the samples, and results showed better blood coagulation for the SPI films containing BGs. 
Moreover, cell culture results indicated that MEF cells could grow better on SPI films 
containing BG especially for SPI-13-93 films compared to pure SPI films. The composition 
and surface topography of the films were the major factors influencing the cellular behavior. 
a b 
Figure 13: SEM images of MEF cells adherent on the 13-93 BG films after 5 days of cultivation. 
a) lower and b) higher magnification. White arrows show the filopodia. 
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It can be thus postulated that these new SPI/BG composite films with appropriate 
cytocompatibility, together with their suitable mechanical and physical properties, offer high 
potential for use as wound dressings. 
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